共 50 条
- [41] Synthesis and biological evaluation of selective ErbB2 (Her2) inhibitors for the treatment of cancerABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231Kauffman, Goss S.Lippa, BlaiseArcari, JoelKwan, Tricia A.Bhattacharya, Samit K.Pustilnik, Leslie R.Su, ChunyanMoyer, James D.Ma, LingCampbell, MarySteyn, Stefan
- [42] Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)SCIENCE SIGNALING, 2018, 11 (551)Cocco, EmilianoCarmona, F. JavierRazavi, PedramWon, Helen H.Cai, YanyanRossi, ValentinaChan, CarmenCownie, JamesSoong, JoanneToska, EnedaShifman, Sophie G.Sarotto, IvanaSavas, PeterWick, Michael J.Papadopoulos, Kyriakos P.Moriarty, AlyssaCutler, Richard E., Jr.Avogadri-Connors, FrancescaLalani, Alshad S.Bryce, Richard P.Chandarlapaty, SaratHyman, David M.Solit, David B.Boni, ValentinaLoi, ShereneBaselga, JoseBerger, Michael F.Montemurro, FilippoScaltriti, Maurizio
- [43] The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapyCANCER CYTOPATHOLOGY, 2019, 127 (07) : 428 - 431Hechtman, Jaclyn F.Ross, Dara S.
- [44] HER2 testing in patients with breast cancerBMJ-BRITISH MEDICAL JOURNAL, 2012, 344Dixon, J. MichaelWilson, VictoriaVerrill, MarkSymmans, W. Fraser
- [45] Measurement of Domain Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast CancerLABORATORY INVESTIGATION, 2015, 95 : 38A - 38ACarvajal-Hausdorf, DanielSchalper, KurtPusztai, LajosPsyrri, AmandaKalogeras, KonstantineKotoula, VasilikiFountzilas, GeorgeRimm, David
- [46] Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cellsJOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (03) : 887 - 901Jeong, JaekwangChoi, JungminKim, WonnamDann, PamelaTakyar, FarzinGefter, Julia V.Friedman, Peter A.Wysolmerski, John J.
- [47] The prognostic value of microarray ERBB2 gene and immunohistochemical stain/FISH of HER2 for early breast cancer patientsEUROPEAN JOURNAL OF CANCER, 2015, 51 : S303 - S303Chen, P. Y.Cheng, S. H. C.Yu, B. L.Chen, C. M.
- [48] Measurement of Domain Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast CancerMODERN PATHOLOGY, 2015, 28 : 38A - 38ACarvajal-Hausdorf, DanielSchalper, KurtPusztai, LajosPsyrri, AmandaKalogeras, KonstantineKotoula, VasilikiFountzilas, GeorgeRimm, David
- [49] Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases(2016)JAMA ONCOLOGY, 2017, 3 (03) : 418 - 418Priedigkeit, N.Hartmaier, R. J.Chen, Y.
- [50] Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast CancerMODERN PATHOLOGY, 2018, 31 : 113 - 113Xia, DanielKuo, FrankDillon, Deborah